4092 Participants Needed

AKI Alerts for Acute Kidney Injury

FP
Overseen ByFrancis P Wilson, MD MSCE
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Yale University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The primary objective of this study is to determine whether the use of uplift (also known as Conditional Average Treatment Effect - CATE) modeling to empirically identify patients expected to benefit the most from AKI alerting and to target AKI alerts to these patients will reduce the rates of AKI progression, dialysis, and mortality.

Do I have to stop taking my current medications for the AKI Alerts trial?

The trial protocol does not specify whether you need to stop taking your current medications.

What data supports the idea that AKI Alerts for Acute Kidney Injury is an effective treatment?

The available research shows mixed results about the effectiveness of AKI Alerts for Acute Kidney Injury. Some studies suggest that these alerts can help in recognizing the condition early, which is crucial for better outcomes. However, other studies, like the one conducted at Brandenburg Medical School, found that the alerts did not significantly improve important outcomes like reducing the need for dialysis or lowering in-hospital death rates. This suggests that while AKI Alerts might help in early detection, they may not always lead to better treatment results unless they are well-integrated with a clinical response plan.12345

What safety data exists for AKI alert systems?

The safety data for AKI alert systems, also known as electronic alerts for acute kidney injury, is primarily focused on their impact on patient outcomes, recognition, and management of AKI. While these systems have been implemented in various electronic health records worldwide, the evidence of their benefit on outcomes remains uncertain. Studies have shown feasibility and some changes in AKI demographics and outcomes following their implementation, but major randomized trials have yet to conclusively demonstrate significant improvements in patient safety or outcomes.14678

Is the treatment called AKI Alerts for Acute Kidney Injury a promising treatment?

Yes, AKI Alerts for Acute Kidney Injury are promising because they help doctors recognize kidney problems earlier, which can lead to better patient care and outcomes.14679

Research Team

F. Perry Wilson, MD, MSCE < Yale School ...

Francis Wilson, MD

Principal Investigator

Yale University

Eligibility Criteria

This trial is for adults over 18 who are hospitalized and have acute kidney injury (AKI) as shown by a significant rise in creatinine levels. It's not open to those already on dialysis, with very high initial creatinine, previous participation, hospice care, recent kidney transplant or opted out of health record research.

Inclusion Criteria

Admitted to a participating hospital
Your kidney function has declined based on specific levels of creatinine in your blood during a short period of time.

Exclusion Criteria

I was prescribed dialysis before my acute kidney injury.
I am currently enrolled in hospice care or receiving comfort-only treatments.
I had a kidney transplant less than 6 months ago.
See 4 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Randomization and Intervention

Participants are randomized into 'recommended' or 'anti-recommended' groups based on uplift scores, and alerts are generated accordingly

14 days
Inpatient monitoring

Follow-up

Participants are monitored for AKI progression, dialysis, or mortality

14 days

Extended Follow-up

Participants are monitored for secondary outcomes such as AKI best practices and readmission rates

Up to one year

Treatment Details

Interventions

  • Alert
Trial Overview The study tests if targeting AKI alerts using uplift modeling to patients most likely to benefit can reduce the worsening of AKI, need for dialysis, or death. The alert aims to prompt timely medical response when a patient's condition indicates risk.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: RecommendedExperimental Treatment1 Intervention
Those whose uplift score represents a probability of benefit greater than 0.5 will generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will not generate an alert.
Group II: Anti-recommendedExperimental Treatment1 Intervention
Those whose uplift score represents a probability of benefit greater than 0.5 will not generate an alert, while those whose uplift score represents a probability of benefit less than 0.5 will generate an alert.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Yale University

Lead Sponsor

Trials
1,963
Recruited
3,046,000+

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials
2,513
Recruited
4,366,000+

Findings from Research

Recent advances in electronic alerts (e-alerts) for acute kidney injury (AKI) have shown promise, particularly with the implementation of a standardized detection algorithm in England that has demonstrated good diagnostic performance.
However, a recent randomized trial indicated that simply using text message e-alerts did not significantly change clinician behavior or improve patient outcomes, highlighting the need for effective communication methods and further research on interventions that can influence clinician actions.
Recent developments in electronic alerts for acute kidney injury.Horne, KL., Selby, NM.[2022]
In a study involving 2413 hospitalized patients with acute kidney injury, the implementation of an automated electronic alert system did not lead to improved clinical outcomes, such as changes in creatinine levels, dialysis rates, or mortality, compared to usual care.
The results showed no significant differences in the severity of kidney injury or patient outcomes at 7 days, indicating that the alert system may not be effective in enhancing the management of acute kidney injury in a hospital setting.
Automated, electronic alerts for acute kidney injury: a single-blind, parallel-group, randomised controlled trial.Wilson, FP., Shashaty, M., Testani, J., et al.[2023]
The implementation of a digitally enabled intervention for detecting and managing acute kidney injury (AKI) in hospitalized patients did not improve the primary outcome of renal function recovery by discharge, indicating that the intervention may need further refinement to enhance clinical effectiveness.
However, the intervention was associated with a significant reduction in healthcare costs by £2123 per patient and a notable decrease in the hospital-wide cardiac arrest rate, suggesting potential benefits in patient safety and cost efficiency.
Implementation of a Digitally Enabled Care Pathway (Part 1): Impact on Clinical Outcomes and Associated Health Care Costs.Connell, A., Raine, R., Martin, P., et al.[2023]

References

Recent developments in electronic alerts for acute kidney injury. [2022]
Automated, electronic alerts for acute kidney injury: a single-blind, parallel-group, randomised controlled trial. [2023]
Implementation of a Digitally Enabled Care Pathway (Part 1): Impact on Clinical Outcomes and Associated Health Care Costs. [2023]
Acute kidney injury demographics and outcomes: changes following introduction of electronic acute kidney injury alerts-an analysis of a national dataset. [2021]
Electronic acute kidney injury alert at the Brandenburg Medical School - implementation and follow-up. [2023]
Does acute kidney injury alerting improve patient outcomes? [2023]
Association between e-alert implementation for detection of acute kidney injury and outcomes: a systematic review. [2022]
Electronic alerts in acute kidney injury: why does evidence of benefit remain elusive? [2023]
Impact of electronic alerts for acute kidney injury on patient outcomes: interrupted time-series analysis of population cohort data. [2022]